- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Shire PLC+ Add to Watchlist
SHPG:US219.2600 USD 2.9100 1.31%
As of 20:10:00 ET on 01/30/2015.
Company Profile for Shire PLC (SHPG)
Shire PLC markets, licenses and develops prescription medicines. The Group focuses its operations on attention deficit and hyperactivity disorders, human genetic therapies, gastrointestinal, and renal diseases.
Key Executives for Shire PLC (SHPG)
|Flemming OrnskovChief Executive Officer||Jeff PoultonInterim CFO/Head:Investor Relations|
|Tatjana MaySecretary/General Counsel|